Future studies exploring the functional association between ER and NF-κB signaling in low DAB2IP ER+ tumors are needed to provide insight into mechanisms whereby this tumor subset exhibits aggressive oncogenic phenotypes. The gene discussed is NFKB1; the disease is neoplasm.